Investor Relations

Press Releases

 
Press Releases
  Date Title View
Mar 9, 2017
MANHASSET, N.Y. and SILVER SPRING, Md., March 9, 2017 /PRNewswire/ -- Northwell Health's Feinstein Institute for Medical Research and United Therapeutics Corporation (NASDAQ: UTHR) announced today a strategic partnership focused on the application of bioelectronic medicine and cell therapy to cardiology, hypertension and post-transplant tolerance i...
Mar 7, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Barclays Global Healthcare Conference in Mi...
Feb 28, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the Cowen and Company 37th Annual Health Care C...
Feb 22, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended December 31, 2016. "Our annual 2016 financial results reflect continued growth as net revenues reached $1.6 billion and earnings exceeded...
Feb 15, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2016 financial results before the market opens on Wednesday, February 22, 2017. United Therapeutics will host a teleconference on Wednesday, Februa...
Jan 5, 2017
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 5, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 35th Annual J.P. Morgan Healthcare Conferenc...
Oct 27, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, 2016. "Our financial performance continues its strength this quarter," said Martine Rothblatt, Ph.D., United Therapeutics' Chairman a...
Oct 20, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2016 financial results before the market opens on Thursday, October 27, 2016. United Therapeutics will host a half-hour teleconference on Thursday, October 27,...
Aug 10, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 2016 Wedbush PacGrow Healthcare Conference ...
Jul 28, 2016
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, 2016. "We are pleased with our second quarter 2016 financial results as total revenues exceeded $400 million and earnings beat $200 milli...
1
... NextLast
= add release to Briefcase